Abstract
Serapiase®, an anti-inflammatory Serrapeptase enzyme, was administered to 100 patients with inflammation caused acute periodontal abcess, periodontitis, radicular cysts, and peri-coronitis, and with post operative inflammation after tooth extraction and gingival flap operation. Clinical studies were performed and the following results were obtained:
1) Serapiase® is particularly effective for inflammation with swelling, and other infected wounds with secretion and necrotic tissues. The efficacy rate was 88.7% by chief doctors and 89.8% by marks.
2) The effectiveness increased when using with antibiotics and particularly better results were gained when using with anti-inflammatory analgesic agents in case of major operations.
3) Obvious side effects were not observed.
